ProVise Management Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.45M | Sell |
|
|||||
|
2025
Q2 | $9.15M | Buy |
|
|||||
|
2025
Q1 | $8.81M | Buy |
|
|||||
|
2024
Q4 | $6.32M | Sell |
|
|||||
|
2024
Q3 | $11.3M | Buy |
|
|||||
|
2024
Q2 | $11.5M | Buy |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $8.94M | Buy |
|
|||||
|
2023
Q3 | $7.3M | Buy |
|
|||||
|
2023
Q2 | $1.71M | Buy |
|
|||||
|
2023
Q1 | $1.76M | Sell |
|
|||||
|
2022
Q4 | $2.2M | Sell |
|
|||||
|
2022
Q3 | $2.71M | Sell |
|
|||||
|
2022
Q2 | $3.19M | Sell |
|
|||||
|
2022
Q1 | $3.67M | Sell |
|
|||||
|
2021
Q4 | $3.64M | Sell |
|
|||||
|
2021
Q3 | $2.95M | Sell |
|
|||||
|
2021
Q2 | $3.05M | Sell |
|
|||||
|
2021
Q1 | $2.91M | Buy |
|
|||||
|
2020
Q4 | $2.27M | Buy |
|
|||||
|
2020
Q3 | $1.72M | Buy |
|
|||||
|
2020
Q2 | $654K | Buy |
|
|||||
|
2020
Q1 | $517K | Buy |
|
|||||
|
2019
Q4 | $589K | Buy |
|
|||||
|
2019
Q3 | $454K | Buy |
|
|||||
|
2019
Q2 | $501K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $4.76K | Buy |
|